Israel Englander’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-256,563
Closed -$6.51M 4746
2019
Q1
$6.51M Buy
256,563
+220,563
+613% +$3.9M 0.01% 1570
2018
Q4
$415K Sell
36,000
-73,175
-67% -$974K ﹤0.01% 3068
2018
Q3
$2.23M Buy
109,175
+73,522
+206% +$1.51M ﹤0.01% 2369
2018
Q2
$570K Buy
35,653
+345
+1% +$4.92K ﹤0.01% 3106
2018
Q1
$507K Buy
+35,308
New +$482K ﹤0.01% 3016
2017
Q4
Sell
-45,573
Closed -$875K 4255
2017
Q3
$875K Buy
+45,573
New +$984K ﹤0.01% 2586

Israel Englander's NITE Position: Q2 2019 in Review

Israel Englander sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q2 2019, closing a stake of 256,563 shares — an estimated $6.51M sold.

Israel Englander first reported a position in NITE in Q3 2017 and held it in 6 quarters. The position peaked at $6.51M in Q1 2019. 0 funds tracked by Wall St. Rank hold NITE as of Q2 2019.

  • Israel Englander reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
  • Israel Englander sold 256,563 Nightstar Therapeutics plc American Depositary Shares shares in Q2 2019, an estimated $6.51M.
  • Israel Englander first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q3 2017 and held it in 6 quarters.
  • Israel Englander's Nightstar Therapeutics plc American Depositary Shares position peaked at $6.51M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q2 2019.

Based on Millennium Management's 13F filing for Q2 2019, filed 14 Aug 2019.